Introduction
The engagement of cell-surface receptors by a ligand regulates a number of biological processes. In the case of receptor tyrosine kinases (RTKs), these processes induce the cell cycle, cell migration, cell metabolism, and survival, as well as cell proliferation and differentiation, all of which depend on the activation of multiple signaling pathways (Hunter, 2000; Schlessinger, 2000) . The mechanisms by which RTKs coordinate a wide variety of intracellular signaling events have been the subject of intense investigation. The Ras/mitogenactivated protein kinase (MAPK) signaling pathway plays an important role in signaling via RTKs. The adaptor protein Grb2 links receptor tyrosine kinases with the Ras signaling pathway by binding to the Rasspecific guanine nucleotide exchange factor (GEF) Sos through its SH3 domains and to tyrosine-phosphorylated receptors via its SH2 domain (Pawson and Gish, 1992) . Recruitment of Sos to membrane-proximal region leads to conversion of GDP-form of Ras to GTP-form of Ras. These membrane-proximal events are transmitted to the ERK MAPK pathway, a three-tiered kinase cascade in which Raf-1 phosphorylates and activates MEK, which in turn phosphorylates and activates ERK. The activated ERK is translocated to the cell nucleus and phosphorylates transcription factors, such as Elk and Myc, resulting in the activation of a set of genes. This linear cascade has been well established, but still seems oversimplified. Additional molecules are likely to be involved in the Ras/MAPK signaling pathway.
Gab-family proteins (Gab1, Gab2, and Gab3) contain a PH (pleckstrin homology) domain in the aminoterminal region, as well as tyrosine-based motifs and proline-rich sequences (PXXP), which are potential binding sites for various SH2 and SH3 domains, respectively (Holgado-Madruga et al., 1996; Gu et al., 1998; Nishida et al., 1999; Zhao et al., 1999; Hibi and Hirano, 2000; Wolf et al., 2002) . Gab proteins are tyrosine-phosphorylated upon stimulation with various extracellular stimuli, and RTK or other tyrosine kinases are often involved in this phosphorylation Liu and Rohrschneider, 2002) . Tyrosinephosphorylated Gab proteins interact with signaling molecules such as SHP-2, p85 PI-3 kinase, PLC-g, CrkL, and Grb2 (Holgado-Madruga et al., 1996; TakahashiTezuka et al., 1998; Nishida et al., 1999; Gu et al., 2000; Sakkab et al., 2000; Schaeper et al., 2000) . Overexpression of Gab1 in cell lines enhances or mimics EGF-mediated cell growth and anchorage-independent transformation (Holgado-Madruga et al., 1996) , HGFmediated cell scattering, branching morphogenesis, and ERK activation (Weidner et al., 1996; Maroun et al., 2000; Schaeper et al., 2000) . Consistent with these observations, Gab1-deficient mice die in utero and display developmental defects in the heart, placenta, liver, and skin (Itoh et al., 2000; Sachs et al., 2000) . These phenotypes are similar to the ones observed in mice deficient for the HGF, PDGF, and EGF signaling pathways. Furthermore, activation of ERK in response to EGF, PDGF, and HGF is strongly reduced in Gab1-deficient primary fibroblasts (Itoh et al., 2000) , indicating that Gab1 acts downstream of the RTKs and upstream of ERK. Similarly, genetic analyses of Drosophila revealed that Daughter of Sevenless (Dos), a Drosophila homologue of Gab proteins, functions downstream of RTKs, Sevenless, Torso, and EGF-receptor, in cooperating with Drosophila SHP-2 homologue Corkscrew (Herbst et al., 1996; Raabe et al., 1996; Herbst et al., 1999; Bausenwein et al., 2000) . These reports indicate conservative roles of Gab/Dos-family proteins in RTK signaling. However, it remains elusive at which level Gab/Dos regulates RTK signaling to ERKs and biological responses.
The EGF family of growth factors consists of at least 10 different members that bind and activate four receptors, namely the EGF-receptor (ErbB1/HER1), ErbB2 (HER/Neu), ErbB3, and ErbB4, which share a common cytoplasmic signaling pathway. Upon the ligand's binding, most ErbBs form both homo-and heterodimers, whereas ErbB2 preferentially composes a heterodimer, and ErbB2-containing heterodimers have attributes that prolong and enhance downstream signaling (Graus-Porta et al., 1997; Olayioye et al., 2000) . It is well known that erbB2/her/neu was isolated as an oncogene that transforms immortalized fibroblasts. Truncation of the extracellular domain of ErbB2 or a mutation that induces dimerization of ErbB2 confers on it the ability to transform cells. A mutation of the c-erbB2 protein with Glu substituted for Val-659 converts it to activated form of erbB2 (active ErbB2) and confers on it the ability to transform cells. Furthermore, the erbB2 gene is amplified and overexpressed in 20-80% of early-stage human breast cancer cases. The expression levels of erbB2 are reported to correlate with the tumor size, and metastasis of the tumor to lymph nodes, implying that erbB2 and erbB2-mediated signals are involved in the tumorigenesis of breast cancer (Hynes and Stern, 1994) .
In this report, we demonstrate, using Gab1-deficient immortalized fibroblasts, that Gab1 acts upstream of Ras for EGF receptor/ErbB-mediated ERK activation. We also found that Gab1 is required for active ErbB2-mediated transformation.
Results

Establishment of wild-type and Gab1 mutant cell lines and impairment of ERK activation in Gab1-deficient cells
To investigate Gab1 functions in mediating the ERK activation, we generated immortalized Gab1À/À, +/À, and +/+ cell lines by transfecting the gene encoding the SV40 large T antigen into embryonic fibroblast cells derived from E12.5 Gab1-deficient mice and their littermates. Consistent with our previous results in primary embryonic fibroblast, we detected Gab1 protein of 120 kDa in Gab1+/+ cell lines (Figure 1a) . However, Gab1 was not detected in Gab1À/À cell lines (Figure 1a) . The growth rate of the homozygous Gab1 mutant cells decreased in response to 1 or 10% serum, compared with wild-type and heterozygous mutant cells (Figure 1c ). EGF-, PDGF-, and IL-6-induced activation of ERK was detected in the Gab1À/À cells at reduced levels ( Figure 1d ). After 15-30 min, the activation of ERK returned to the basal level. In contrast, the level of FGF-induced ERK activation was not significantly different between Gab1À/À and Gab1+/À cells during the time course. These data suggest that Gab1 is involved in at least the maintenance of ERK activation by EGF, PDGF, and IL-6, but not by FGF, in fibroblasts.
Pinpointing the role of Gab1 in the Ras-ERK pathway Next we examined which level(s) in the ERK signal transduction cascade is affected by the Gab1 deficiency. We focused on the signaling of the EGF receptor. Gab1+/À and Gab1À/À cell lines were stimulated with EGF for 5, 15, and 30 min, and the activation of MEK1/ 2 was determined by immunoblotting using antibodies that specifically recognize the active MEKs, which are phosphorylated by Raf. EGF induced the activation of the MEKs in Gab1+/À cells, with kinetics similar to that for ERK kinase induction. However, MEK activation by EGF was significantly diminished in Gab1À/À cells, in a manner similar to the pattern of reduced ERK induction (Figure 2a) . We also examined the activation of c-Raf, the kinase that activates MEKs, by an in vitro kinase assay using a recombinant kinaseinactive MEK kinase as the substrate. EGF-induced cRaf activity was attenuated and decayed much faster in Gab1À/À cells than in Gab1+/À cells ( Figure 2a ). As Raf is apparently activated by binding to active Ras in its GTP-bound form, we next examined Ras activation in Gab1+/À and Gab1À/À cells, by measuring the GTP-bound (active) Ras, after EGF stimulation for 1, 2, and 5 min. The amount of GST-Raf bound Ras was significantly lower in Gab1À/À cells than Gab1+/À cells at 2 min (Figure 2a ). We did not observe any difference between the time course of the EGF-induced tyrosine phosphorylation of EGFR or Shc between the Gab1À/À and +/À cell lines (Figure 2b ). Together, these results suggest that reduced ERK kinase activation in Gab1À/À cells is because of an incomplete or abortive induction of Ras, Raf, and MEK activities.
Gab1 effects the activation of ERK by modulating GEF activity
Ras activity is regulated by the opposing effect of guanine nucleotide exchange factors (GEFs), such as Sos, and the Ras GTPase-activating protein. To explore the biochemical basis for Gab1 function in promoting Ras activation, we examined GEF activity and GAP activity between the control and mutant cell lines before and after EGF stimulation. We found that in Gab1-deficient cells, the GEF activity decreased in response to EGF (Figure 3a) . However, there was no difference in the percentage of GTP-bound Ras (a measure of GAP activity) between Gab1+/À and Gab1À/À cells (Figure 3b ). One possible explanation of the failure to activate ERK in the Gab1-deficient cells could be a decrease in GEF activity. We therefore tested whether active Sos constructs introduced into Gab1À/À cells could restore ERK activation. Constitutively active Sos proteins can be obtained by targeting variants of Sos to the membrane via the addition of farnesylation signals (Aronheim et al., 1994) . As shown in Figure 3c , the transfection Gab1À/À cells with active Sos constructs restored the ERK activity. These results suggest that reduced Ras activities in Gab1À/À cells were because of the impairment of Sos for targeting to the membrane.
Rescue of defective ERK activity by Gab1 constructs in Gab1À/À cells
To assess the involvement of Gab1 in the ERK activation pathway, we constructed a series of Gab1 mutants and then stably transfected the Gab1À/À cells with the different Gab1 constructs (Figure 4a ). We then checked the expression levels of the Gab1 mutant proteins. All the transfected cell lines expressed the mutant proteins at levels similar to full-length HAGab1 (Figure 4b) . The Gab1 proteins level in Gab1+/+ was similar to full-length HAGab1. Furthermore, Gab1 Gab1 and Gab2 proteins were detected by immunoprecipitation. As expected, in the Gab1À/À cells, no Gab1 protein was detected. Gab2 proteins were detected in both cell lines. (b) Gab1 and Gab2 mRNA in immortalized cell lines. Gab1 and Gab2 mRNA was detected by using the reverse transcription-polymerase chain reaction (RT-PCR) method. (c) Serum response and cell proliferation of immortalized cells. A total of 10 5 cells per 60-mm dish were cultured in serum-free DMEM, DMEM containing 1% FBS, or DMEM containing 10% FBS. Cell counting was performed after 1, 2, and 3 days. (d) Reduced activation of ERK MAP kinase in Gab1À/À cells in response to EGF, PDGF, and IL-6 plus soluble IL-6 receptor complex (IL-6/sIL-6R), but not bFGF. Gab1+/À and Gab1À/À cells were serum starved, then stimulated for 5, 10, 30, or 90 min with 100 ng/ml EGF, 50 ng/ml PDGF, 100 ng/ml IL-6/sIL-6R, or 100 ng/ml bFGF. The cells were then lysed and subjected to Western blot analysis using a polyclonal antibody against active MAP kinase or ERK. ERK1/2 phosphorylation was normalized to total ERK, using a LAS1000 plus. The maximum of ERK activation was assigned values of 100%. Solid and dashed lines represent Gab1+/À and Gab1À/À cells, respectively. All data shown are one representative result from three independent experiments that had a similar result b Figure 2 Pinpointing the role of Gab1 in the Ras-ERK pathway. (a) Reduced activation of ERK, MEK, Raf, and Ras, in Gab1À/À cells in response to EGF. ERK and MEK activities in Gab1+/À and Gab1À/À cells were determined by the level of their phosphorylation. Starved cells were stimulated 5, 15, or 30 min with 100 ng/ml EGF, then lysed and immunoblotted using a polyclonal antibody against active MEK and ERK, respectively. Raf-1 activity was determined by a Raf-1 kinase assay. Cell lysates were immunoprecipitated with an anti-Raf-1 antibody. The kinase reaction was performed by incubation with recombinant, inactivated MEK1, at 301C for 30 min. Ras activity was determined by a Raf-RBD pull-down assay. Cell lysates were incubated with 10 mg of GST-c-Raf-1-RBD fusion proteins. The GST-c-Raf-1-RBD/ Ras-GTP complexes were collected on glutathione-sepharose beads, and Ras-GTP was detected using an anti-Ras antibody. The maximum of ERK, MEK, Ras, and Raf activation were assigned values of 100%. All data shown are one representative result from three independent experiments that had a similar result. RA, relative activity. (b) The phosphorylation of Shc and the EGF receptor was normal in Gab1-deficient cell lines. Gab1+/+ and Gab1À/À cells were stimulated with EGF (100 ng/ml) for the indicated periods. Cell lysates were immunoprecipitated with antiShc or anti-EGF receptor antibodies, and subjected to immunoblotting with antiphosphotyrosine (4G10) antibodies Gab1 for active ErbB2 mediated transformation S Yamasaki et al rescue the activation after 30 min. These results indicate that the MBD domains, and Y627 and Y659, both of which are SHP-2 binding sites, are crucial for Gab1-medated-ERK activation.
Requirement of Gab1 for active ErbB2-mediated transformation
Cell transformation by oncogenes represents an alternative approach to examine the integrity of growthdependent pathways. To examine the role of Gab1 in ErbB2-induced transformation, constitutively activated ErbB2 (active ErbB2) and Sos (active Sos) were introduced into Gab1+/+, +/À, and À/À cells, and transformants were selected by treatment with antibiotics. First, we examined whether the growth rate of active ErbB2-transfected Gab1À/À cells was decreased compared with wild-type cells in response to 10% serum in liquid culture. To avoid possible clonal deviations contributing to cell growth, we used transfected cell pools instead of single-cell clones. The growth rate of active ErbB2-transfected Gab1À/À cells was decreased compared with wild-type cells in response to 10% serum in liquid culture. The reintroduction of wild-type Gab1 restored the growth rate of the Gab1À/À cells ( Figure 5a) . Next, the transforming activity of active 
ErbB2 or active Sos in these cells was analysed by anchorage-independent cell growth. Transfection of active Sos into Gab1+/À and À/À cells produced a similar number of colonies (Figure 5b) . However, the number of active ErbB2-induced colonies was very much reduced for Gab1À/À cells, compared with the number for Gab1+/À cells (Figure 5b ). To assess the involvement of Gab1 in active ErbB2-mediated transformation, we transfected active ErbB2 into the Gab1À/ À cell lines that expressed the series of Gab1 mutant constructs shown in Figure 4a . The expression of fulllength HAGab1 and Gab1 F447/472/589 in Gab1À/À cells rescued colony formation (Figure 5c ). However, neither Gab1 F627/659 , Gab1
DPH
, nor Gab1 DMBD rescued colony formation (Figure 5c ). These results indicate that the SHP-2-binding site, PH domain, and MBD domain of Gab1 are required for active ErbB2-mediated transformation. Finally, to evaluate the role of Gab1 in tumor growth, we implanted active ErbB2-transfected pooled cells into immunocompromised (nude) mice. The Gab1+/À transfectants formed tumors in the nude mice. However, the Gab1À/À transfectants did not form tumors (Figure 5d ). On the other hand, Gab1À/À cells transfected with active Sos formed tumors in nude mice Figure 4 Gab1-SHP-2-binding mutant fails to rescue EGF-mediated ERK MAP kinase activation. (a) Gab1 expression constructs used in this study. The major functional domains of Gab1 were described previously (Nishida et al., 1999) . (b) The Gab1 constructs were expressed at equivalent levels. Gab1-deficient cell lines were stably transfected with wild-type Gab1 and the mutant constructs. Proteins from cell lysates were immunoprecipitated with an anti-HA antibody, and the immune complexes were detected with the same antibody. (c) The Gab1-Y447/472/589F and Y627/659F mutant proteins were crucial for the interaction with p85 and SHP-2, respectively. The cell lysates were immunoprecipitated with the anti-HA antibody and the immune complexes were detected with an anti-p85 or anti-SHP-2 antibody. (d) The Gab1 mutant cell lines were serum starved for 12 h, then stimulated for the indicated times with 100 ng/ml EGF. These cells were lysed and subjected to Western blot analysis using a polyclonal antibody against active MAP kinase. An antibody against p42MAP kinase was used to show that the lanes were loaded with approximately the same amount of protein. The maximum of ERK activation was assigned values of 100%. Data shown here are one of the representative results from independent experiments using several clones Gab1 for active ErbB2 mediated transformation S Yamasaki et al at a level similar to the control cells (Figure 5d ). These results indicate that Gab1 is specifically required for active ErbB2-mediated tumor formation.
Discussion
Molecular mechanism of Gab1 function in Ras activation
Overexpression of Gab1 in cell lines induces or enhances the growth factor receptor-mediated activation of ERK MAP kinase (Holgado-Madruga et al., 1996; Takahashi-Tezuka et al., 1998) . Disruption of the Gab1 gene in mouse fibroblasts leads to defects in the growth factorand cytokine-induced ERK activation, in which receptor tyrosine kinases or receptor-associated tyrosine kinases are involved (Itoh et al., 2000; Sachs et al., 2000) . Drosophila genetics have also been implicating that the Drosophila Gab1 homologue Dos functions downstream of receptor tyrosine kinases and involved in biological responses involving the Drosophila ERK Transformation of fibroblasts by active ErbB2 depends on Gab1. (a) The growth rate of active ErbB2-transfected Gab1À/À cells was significantly decreased in response to serum than was the growth rate of active ErbB2-transfected Gab1+/À cells. Reconstitution of wild-type Gab1 restores the growth rate of active ErbB2-transfected Gab1À/À cells. Gab1À/À cells that stably expressed wild-type Gab1 (HAGab1) were transfected with active ErbB2. The active ErbB2-transfected cells were selected with antibiotics, and resistant cells (1 Â 10 5 ) were seeded in 35-mm dishes. The cells were trypsinized, and viable cells were counted following staining at the indicated time using the trypan blue exclusion method. (b) Soft agar colony assay in active ErbB2-transfected Gab1+/À and Gab1À/À cells. Gab1+/À and Gab1À/À cells were transfected with active ErbB2 or the active Sos expression vector. The cells were selected by antibiotic treatment. The ability to form colonies in soft agar was scored. (c) Gab1À/À cells expressing the series of Gab1 mutant constructs were transfected with active ErbB2, and the ability of cells to form colonies in soft agar was scored with at least four independent experiments. (d) Tumorigenicity was assayed after the subcutaneous injection of 1 Â 10 7 cells into nude mice. Tumors were measured with calipers and the volume was calculated. All data were expressed as mean7s.d. of 3 mice. ND, no detectable tumor formation Gab1 for active ErbB2 mediated transformation S Yamasaki et al homologue Rolled (Herbst et al., 1996; Raabe et al., 1996) . There was no report, however, providing biochemical data that indicate at which levels Gab1 regulates signaling of receptor tyrosine kinases to ERK.
In this report, we demonstrated that Gab1 functions upstream of Ras in the EGF-R signaling to ERK by using Gab1-deficient cell lines. We found that EGFdependent activation of c-Raf and Meks, which act downstream of Ras and upstream of ERKs, were suppressed in Gab1À/À cells (Figure 2) . Furthermore, GTP-form of Ras was reduced in EGF-stimulated Gab1À/À cells. Concomitantly with this, GDP/GTP exchange activity for H-Ras was diminished in these cells (Figure 3 ). These data clearly indicate that Gab1 functions at least upstream of Ras, most likely for the regulation of activity of GDP/GTP exchanger, in EGF-R signaling to ERK activation. This is consistent with that activated (membrane-anchored) form of the GDP/ GTP exchanger Sos could rescue the ERK activation in Gab1À/À cells. How does Gab1 regulate Ras GDP/ GTP exchanging factor? One possibility is that Gab1 is involved in membrane recruitment of Ras guanine nucleotide exchanger, such as Sos, since membrane localization is known to be an essential event for RTKmediated Ras activation and membrane-recruitment of Sos is shown to be sufficient for activation of the downstream cascades (Simon et al., 1991; Aronheim et al., 1994) . However, our preliminary data showed that protein amount and subcellular localization of Sos were not different between EGF-stimulated Gab1À/À and the wild-type cells (data not shown). It is possible that only a part of Sos can be recruited in a Gab1-dependent manner, which is below the detection levels, or Sos may be recruited into a subdomain of membrane proximal region as proposed for a microdomain, a raft, or an immune synapse. Alternatively, Gab1 is involved in the regulation of the Sos activity in a manner different from the membrane recruitment. It is reported that Sos is regulated by an intramolecular interactions in addition to the membrane recruitment (Das et al., 2000) . Gab1-mediated biochemical event might modulate the intramolecular interaction of Sos and release the autoinhibition, resulting in the upregulation of the exchange activity for Ras. It is also possible that Gab1 may regulate activity of other Cdc25-related Ras GTP/GDP exchanging factors, such as Ras-GRF1 and Ras-GRF2 (Anborgh et al., 1999) . Further biochemical analyses using Gab1À/À cell lines will clarify the mechanisms by which Gab1 controls the GTP/GDP exchange activities for Ras.
Involvement of Gab1 in prolonged ERK activation in EGF-R signaling
When the Gab1À/À cells were stimulated with EGF, the phosphorylation level of ERK at 5 min after the stimulation was almost the same as that of the control cells, but it decreased more rapidly 15 min after the stimulation in Gab1À/À cells than in the control cells (Figure 1 ). Similar results were obtained when Gab1À/À cells were treated with PDGF and IL-6. These data suggest that Gab1 is required for long-term signaling through the Ras-ERK MAP kinase pathway. Prolonged activation of ERK is shown to be involved in the transformation of NIH3T3 cells (Cowley et al., 1994) . Reduction in sustained activation of ERK might lead to defects in transformation and tumorigenesis of active ErbB2-transfected Gab1À/À fibroblast cells. Expression of Gab1 DPH in Gab1À/À cells partially rescued an early phase (within 10 min) of EGF-dependent ERK activation, but did not fully rescue the activation after 30 min (Figure 4) , suggesting that the PH domain is involved in prolonged activation of the signal to ERK. Since Gab1 interacts with EGF-R directly or indirectly through Grb2 (Lock et al., 2000; Rodrigues et al., 2000) , Gab1
DPH is likely recruited to the plasma membrane by EGF-R in the early phase of the EGF stimulation. Consistent with this, a Gab1
DPH was tyrosyl phosphorylated after EGF stimulation (data not shown) and binds SHP-2 (Figure 4c ). The PH domain may be required to maintain the membrane localization of Gab1 in the cells. The PH domain is known to interact with PI-3, 4, 5P 3 , the product of PI-3 kinase, which exists on inside of the plasma membrane. It is plausible that membrane localization of Gab1 is initiated by interaction with EGF-R and sustained by the interaction between the PH domain and the PIP3.
Role of adapter molecule Gab1 for active ErbB2-mediated transformation
We found that Gab1 is required for active ErbB2-induced anchorage-independent cell growth. Furthermore, we showed that active ErbB2-transfected Gab1À/ À cells injected into nude mice did not form tumors at 3 weeks after transplantation, indicating an essential role of Gab1 in active ErbB2-mediated transformation ( Figure 5 ). In contrast, active Sos-induced transformation did not require Gab1, consistent with the idea that Gab1 functions upstream of Ras. Proliferation of active ErbB2-transfected Gab1À/À cells was significantly decreased, compared with that of active ErbB2-transfected wild-type cells (Figure 5 ), while the growth rate of Gab1À/À cells transfected with active Sos was similar to that of control cells (data not shown). The data indicate that reduction of cell proliferation of the active ErbB2-transfected Gab1À/À cells is likely attributed to reduction or loss of transformation and tumorigenicity of these cells. Gab1-mediated signals are thus required for EGFR/ErbB-mediated cell proliferation and oncogenesis.
Expression of Gab1 mutants in Gab1À/À cell revealed that the SHP2-binding sites were indispensable for both EGF-mediated ERK activation and the active ErbB2-mediated transformation, further supporting a cooperative role of SHP-2 for Gab1 activation and/or effector function of SHP-2 downstream of Gab1. Genetic analyses of SHP-2-deficient mice show that the SHP-2 deficiency strongly linked to waved, a point mutation of EGFR (Qu et al., 1999; Chen et al., 2000) . Furthermore, EGFR-mediated signaling, including activation of ERKs, is strongly perturbed in the SHP-2-deficient fibroblast cell. All of these data, together with our data, imply that SHP-2 and Gab1 are essential components that function downstream of EGFR.
In summary, the results in this paper show a critical role for Gab1 in active ErbB2-mediated transformation and provide a basis for elucidating the molecular mechanism of Gab1-mediated ERK MAP kinase activation. We show that Gab1 is a crucial signaling molecule required for EGF/ErbB family signaling pathways by modulating Ras-GTP levels. Owing to its role in this process, the adapter molecule Gab1 may become an attractive target for the pharmacological intervention of malignant cell growth.
Materials and methods
Fibroblast cell lines, stimulation, and transfection
Mouse embryonic fibroblast cells were isolated by trypsinizing tissue from embryonic day 12.5 littermate embryos obtained from crosses between heterozygous Gab1-deficient mice. Primary cells were incubated in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin, and were immortalized by transfection with an expression vector bearing the SV40 Large T antigen gene. Successful immortalization of the embryonic fibroblast cell line was confirmed using an anti-SV40 T Ag antibody (Santa Cruz). The genotypes of the cell lines were established by PCR and immunoblot analysis, as described previously. For stimulation experiments, cells (2 Â 10 6 ) were serum starved for 12 h, then stimulated with 100 ng/ml human recombinant epidermal growth factor (EGF, PeproTech), 50 ng/ml human recombinant platelet-derived growth factor (PDGF-BB, Gibco), 100 ng/ml human recombinant basic fibroblast growth factor (bFGF, Invitrogen), 100 ng/ml human recombinant IL-6/soluble IL-6 receptor, a fusion protein, for the indicated times. At the end of the stimulation, the cells were immediately washed with PBS and lysed in 1 ml ice-cold lysis buffer. Transfections were carried out using the FuGENE6 reagent (Roche) according to the manufacturer's instructions.
Plasmid construction
The mutant alleles of Gab1 used in this study are depicted in Figure 4a . To construct the Gab1 mutant Gab1 F447/472/589 , tyrosines 447, 472, and 589 of human Gab1, corresponding to the YXXM motifs, were mutated to phenylalanines by PCRbased mutagenesis using pcDNA3-HA (hemagglutinin)-Gab1. The Gab1 mutant Gab1 F627/659 was constructed by replacing tyrosines 627 and 659, corresponding to the YLDL and YVVV motifs, with phenylalanines. The Gab1 mutant Gab1DPH was constructed by removing amino acids 14-116 of human Gab1. The Gab1DMBD was constructed by removing amino acids 449-531 of human Gab1. For stable transfections, Gab1 cDNA was subcloned into the pCAGIPuro expression vector (a gift from Dr H Niwa), which bears a puromycin-resistance gene. Primers used for the mutagenesis are available on request. The active forms of ErbB2 (ErbB2,V659E) (a gift from Dr T Yamamoto) and Sos (active Sos) (a gift from Dr A Aronhemi) were previously described (Akiyama et al., 1991; Aronheim et al., 1994) .
Immunoprecipitation, immunoblotting, and antibody preparation
After stimulation, cells were lysed with lysis buffer: 20 mm Tris-HCl pH 7.4, 150 mm NaCl, 1% NP40, 1 mm Na 3 VO 4 , 3 mm EDTA, 1 mm phenymethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 5 mg/ml aprotinin, and 1 mm b-glycerophosphate. The lysates were incubated at 41C for 30 min and were cleared by centrifugation at 20 000 g for 30 min. The cleared lysates were incubated with 1 mg of monoclonal antibodies (anti-HA and Flag antibodies) or 1 ml of antiserum (anti-Gab1 antibody) or polyclonal antibodies, and 10 ml of protein A sepharose (Pharmacia). After 10 h of incubation at 41C, immunoprecipitates were washed five times with 1 ml of the lysis buffer without the protease inhibitors. Proteins were eluted with Laemmli's SDS loading buffer, separated on a 4-20% gradient SDS-polyacrylamide gel (Daiich Kagaku), and electro-transferred to a PVDF membrane (Immobilon-P, Millipore). The membranes were visualized using the Renaissance chemiluminescence system (Dupont NEN Product). The anti-Gab1 antibody, which recognizes amino acids 472-694 of human Gab1, was described previously (Takahashi-Tezuka et al., 1998) . The Anti-HA (12CA5) and anti-Flag (M2) antibodies were purchased from Boehringer Mannheim and Sigma Corporation, respectively. The anti-SHP-2 (sc 280), anti-EGFR, and anti-Sos1 antibodies were purchased from Santa Cruz Biotech Co. The antiphosphotyrosine (4G10) and anti-p85 PI-3 kinase antibodies were purchased from UBI Co.
Ras, Raf, MEK, and ERK activity measurement GTP-bound Ras was measured as described previously (de Rooij and Bos, 1997) . Briefly, cells were serum starved for 16 h in the absence of FBS, and the cells were stimulated with EGF (100 ng/ml) for the indicated times. The cells were lysed with lysis buffer. The lysates were cleared by centrifugation. The cleared lysates were incubated with 10 mg of GST-cRaf-1-RBD fusion protein (amino acids 51-131, a kind gift from Dr S Hattori) and 10 ml of glutathione-sepharose (Pharmacia). The GST-c-Raf-1-RBD/Ras-GTP complex was collected by incubation with glutathione-sepharose beads and separated on an SDS-polyacrylamide gel. The GTP-bound Ras was visualized by immunoblotting with anti-Ras antibodies. To measure Raf activity, the cell lysate was immunoprecipitated with anti-Raf-1 antibody (C-12, Santa Cruz) and immunoprecipitates were washed three times with lysis buffer without protease inhibitors and once with kinase buffer (30 mm HEPES pH 7.4, 10 mm MnCl 2 , 5 mm MgCl 2 , 100 mm Na 3 VO 4 , 25mm b-glycerophosphate, 1 mm DTT). The kinase reaction was performed by incubation with 20 ml of kinase buffer containing recombinant MEK1 (inactivated form purchased from UBI) at 301C for 30 min. The phosphorylated substrates were separated by SDS-polyacrylamide gel electrophoresis, and the incorporated 32 P was quantified with a BAS2500 image analyzer (Fuji Film). To measure MEK1/2 and ERK1/2 activity, the total cell lysates were immunoblotted with antidiphospho-ERKs (Promega), anti-ERK2 (C-14, Santa Cruz), antidiphosphoMEKs (Ser217/221, BioLabs), and anti-MEK1/2 (BioLabs) antibodies.
GEF and GAP activity measurement
Total cell GEF activity was measured as previously described (Buday and Downward, 1993) , with some modifications. Briefly, Gab1À/À and control cells were grown in 10-cmdiameter dishes until just confluent. They were then serum starved for 12 h. The cells were washed with warm PBS then Gab1 for active ErbB2 mediated transformation S Yamasaki et al placed in 3.2 ml of permeabilization buffer (150 mm KCl, 37.5 mm NaCl, 6.25 mm MgCl 2 , 1 mm EGTA, 0.8 mm CaCl 2 , 1.25 mm ATP, 12.5 mm PIPES, pH 7.4) at 371C. A 0.8-ml volume of streptolysin O (2 IU/ml in water; Sigma) and 5 mCi of [a-32 P]GTP(3000 Ci/mmol; Amersham) were added, and after a 5-min incubation, EGF (final concentration of 100 ng/ ml) was added. After the incubation, cells were lysed in 1 ml of 10 mm PIPES buffer, pH 7.2, containing 120 mm KCl, 30 mm NaCl, 5 mm MgCl 2 , 100 mm CaCl 2 , 1% Triton X-100, and 10% glycerol. To this was added a solution of 0.5 m NaCl, 0.5% (w/v) sodium deoxycholate and 0.05%(w/v) SDS (final concentrations), and Ras was collected by incubation for 1 h with an anti-Ras monoclonal antibody Y13-259 (Sigma) prebound to protein G-Sepharose. Immunoprecipitates were collected and washed four times in 50 mm HEPES (pH 7.4), 500 mm NaCl, 5 mm MgCl 2 , 0.1% (v/v) Triton X-100, and 0.005% (w/v) SDS. GTP/GDP bound to Ras was eluted in 2 mm EDTA, 2 mm DTT, 0.2% (w/v) SDS, 0.5 mm GTP, 0.5 mm GDP at 681C for 20 min and separated on PEI cellulose F TLC plastic sheets (Merck) in 1 m KH 2 PO 4 , pH 3.4. The amounts of GTP and GDP were measured with a BAS 2500 image analyzer (Fuji Film Co.) .
To measure GAP activity, the cell culture and starvation were the same as that for the GEF assay. Pure bacterially expressed wild-type human Ras (50 ng) was allowed to bind 25 mCi of [a-
32 P]GTP in 20 mm Tris-HCl, pH 8.0, 2 mm DTT, 5 mm EDTA at 371C for 5 min. Streptolysin O, EGF, and [a-32 P]GTP-loaded Ras were added simultaneously. Cells were lysed in 1 ml 1% NP-40 lysis buffer containing 100 mm NaCl, 10 mm MgCl 2 , 1 mg/ml leupeptin, 1 mg/ml pepstatin, 100 mm GTP, and 100 mm GDP. The Ras was collected and the amount of Ras-bound nucleotides was measured as for the GEF assay.
Tumorigenicity assays
Fibroblast cell lines were plated at 1 Â 10 6 cells per 10-cm dish. After 24 h, they were transfected with active ErbB2 and active Sos expression plasmid vectors using the FuGENE6 reagent. The cells were selected with antibiotics for 14 days. For the colony assay, the transfected cells (1 Â 10 3 ) were suspended in DMEM containing 10% FBS and 0.4% agar (FMC BioProducts), then plated into a well that was precoated with 0.5% agar. The number of colonies was counted 2-3 weeks after plating. For the tumorigenicity assays, 1 Â 10 7 cells were injected subcutaneously into 8-to 10-week-old nude mice. The size of each tumor was measured with calipers and the volume was calculated.
